Showing results (1491-1500 of 2,134) with videos related to

Sort By:
Pageof 214
Clinical and Experimental Dermatology|May 11, 2024
Impact of disease, musculoskeletal symptoms and disease control in the CorEvitas Psoriasis RegistryCarly Grant, Lourdes M Perez-Chada, Ryan W Harrison, et al.
Optics Letters|February 14, 2025
High-energy transient gas pinholes via saturated absorptionK Ou, V M Perez-Ramirez, S Cao, et al.
Journal of the American Heart Association|November 3, 2025
Foster Care Status as an Understudied Social Driver of Health Outcomes for Children Needing Cardiac SurgeryAnna Martens, Kimberlee Gauvreau, Taylor Smith, et al.
The Journal of Rheumatology|July 15, 2023
Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual MeetingMelissa P Zundell, Michael J Woodbury, Kathryn Lee, et al.
Pest Management Science|September 18, 2002
Population changes in Phytophthora infestans in Taiwan associated with the appearance of resistance to metalaxylKenneth L Deahl, Louise R Cooke, Lowell L Black, et al.
Annales De Pathologie|January 1, 1989
[Growth fraction (Ki67), ploidy balance and proliferation index in tumors of the urogenital tract and breast]C Charpin, M C Habib, L Piana, et al.
Journal of Plastic Surgery and Hand Surgery|November 26, 2022
Outcomes of perineal wound closure techniques after abdominoperineal resections in rectal cancer: an NSQIP propensity score matched studyJose L Cataneo, Sydney A Mathis, Diana D Del Valle, et al.
Journal of the American Chemical Society|June 15, 2023
Semi-Synthetic CoA-α-Synuclein Constructs Trap N-Terminal Acetyltransferase NatB for Binding Mechanism StudiesBuyan Pan, Sarah M Gardner, Kollin Schultz, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazoleA E Paniz Mondolfi, C Stavropoulos, T Gelanew, et al.
British Journal of Pharmacology|September 15, 2011
Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonistM Dumas, F Nadal-Wollbold, P Gaussem, et al.
Pageof 214